These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30825953)

  • 1. Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications.
    Giguère P; Nhean S; Tseng AL; Hughes CA; Angel JB
    Can J Cardiol; 2019 Mar; 35(3):326-340. PubMed ID: 30825953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.
    Kreutzwiser D; Tseng A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1211-24. PubMed ID: 27376653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
    Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: mixing new cocktails: drug interactions in antiretroviral regimens.
    Young B
    AIDS Patient Care STDS; 2005 May; 19(5):286-97. PubMed ID: 15916491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection.
    Gedela K; Vibhuti M; Pozniak A; Ward B; Boffito M
    HIV Med; 2014 May; 15(5):257-68. PubMed ID: 24351025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interactions in the management of HIV infection.
    Robertson SM; Penzak SR; Pau AK
    Expert Opin Pharmacother; 2005 Feb; 6(2):233-53. PubMed ID: 15757420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
    Barbaro G; Klatt EC
    Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Weight-Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug-Drug Interactions with Antiretroviral Therapy.
    Cope RJ; Fischetti BS; Kavanagh RK; Lepa TM; Sorbera MA
    Pharmacotherapy; 2019 Dec; 39(12):1204-1215. PubMed ID: 31602703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of drug-drug interactions and impact on the effectiveness of antiretroviral therapy among patients living with HIV followed at an Infectious Diseases Referral Center in Belo Horizonte, Brazil.
    Pontelo BM; Greco DB; Guimarães NS; Rotsen N; Braga VAR; Pimentel PHN; Barbosa H; Barroso TM; Tupinambás U
    Braz J Infect Dis; 2020; 24(2):104-109. PubMed ID: 32360120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-related cardiovascular disease and drug interactions.
    Nanavati KA; Fisher SD; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2004; 4(5):315-24. PubMed ID: 15449973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine.
    Podzamczer D
    AIDS Rev; 2013; 15(4):195-203. PubMed ID: 24192600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between recreational drugs and antiretroviral agents.
    Antoniou T; Tseng AL
    Ann Pharmacother; 2002 Oct; 36(10):1598-613. PubMed ID: 12243611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.
    Lai AR; Tashima KT; Taylor LE
    AIDS Patient Care STDS; 2006 Oct; 20(10):678-92. PubMed ID: 17052138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Drug-Drug Interactions in HIV Treatment.
    Devanathan AS; Anderson DJC; Cottrell ML; Burgunder EM; Saunders AC; Kashuba ADM
    Clin Pharmacol Ther; 2019 Jun; 105(6):1362-1377. PubMed ID: 30739315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between methadone and medications used to treat HIV infection: a review.
    Gourevitch MN; Friedland GH
    Mt Sinai J Med; 2000; 67(5-6):429-36. PubMed ID: 11064494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe or life-threatening interactions between antiretrovirals and non-HIV drugs].
    Manzardo C; Tuset M; Miró JM; Gatell JM
    Enferm Infecc Microbiol Clin; 2015; 33(7):e15-30. PubMed ID: 24913990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.